The news comes after Amazon announced their agentic health AI system.

Plaintiff claims a 401(k) fund's high-carbon investments and poor performance may put participants' savings at financial risk.

The letters, sent Feb. 20 and made public this week, cite false or misleading claims about compounded glucagon-like peptide‑1 medications on company websites.

The company denies wrongdoing in resolving claims over recordkeeping fees and forfeitures.

The hospital alleges $1.4 million in withheld post-bankruptcy payments following an earlier $250 million reimbursement lawsuit.

Bonuses will be 42.3% above baseline levels, according to records reviewed by Bloomberg News — a sharp reversal from 2024, when payments were more than 60% below target.

Regulators claim the hospital system blocks insurers from offering lower-cost, innovative health plans.

EBRI finds utilization remains low, but seven-figure treatments pose growing risk for smaller self-insured employers.